tm logo
BOEHRINGER INGELHEIM
Live/Registered
REGISTERED

on 19 May 2020

Last Applicant/ Owned by

Serial Number

87626563 filed on 28th Sep 2017

Registration Number

6055917 registered on 19th May 2020

in the Principal Register

Correspondent Address

Mr. Martin J. Beran

Mr. Martin J. Beran

8th Floor

845 Third Avenue

NEW YORK NY 10022

Filing Basis

1. intent to use

Disclaimer

NO DATA

BOEHRINGER INGELHEIM

pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of blood and blood forming organs; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular sy Read More

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of blood and blood forming organs; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system; dermatologicals; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of the genitourinary system; hormones; anti-infectives; pharmaceutical preparations, namely, blood plasma expanders; pharmaceutical preparations, namely, blood and plasma substitute solutions; saline solution for medical purposes; sterile sodium chloride solutions for medical purposes; cleansing solutions for medical use; pharmaceutical solutions used in dialysis; cytostatics for pharmaceutical purposes; cytostatics for medical purposes; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the musculoskeletal system; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the peripheral nervous system; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system; pharmaceutical products for ophthalmological use; ophthalmological preparations; pharmaceutical products for use in otology; pharmaceutical preparations, namely, anti-allergic agents; diagnostic radiopharmaceutical preparations for clinical, medical, scientific and research use; antiseptic preparations; pharmaceutical preparations and medicines, namely, for parenteral nutrition and intravenous parenteral nutrition; medical diagnostic reagents

Class [010]
Medical Instrument Products


Therapeutic apparatus for dispensing pharmaceutical preparations

Mark Details


Serial Number

No 87626563

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TE/3975-206

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

06.07.01 -

Cities from a distant perspective, skylines

25.03.25 -

Backgrounds covered with other figurative elements or repetitive designs, words or letters

26.01.02 -

Plain single line circles

26.11.02 -

Plain single line rectangles

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.04 -

Vertical line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
19th May 2020REGISTERED-PRINCIPAL REGISTER
03rd Mar 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03rd Mar 2020PUBLISHED FOR OPPOSITION
12th Feb 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29th Jan 2020APPROVED FOR PUB - PRINCIPAL REGISTER
17th Jan 2020TEAS/EMAIL CORRESPONDENCE ENTERED
16th Jan 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
16th Jan 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
16th Jul 2019NON-FINAL ACTION E-MAILED
16th Jul 2019NON-FINAL ACTION WRITTEN